New migraine drug affordably priced at only $6,900 a year
Pharmaceutical execs say promising treatment for chronic headaches is fairly priced, but it still costs a bundle
Pharmaceutical execs say promising treatment for chronic headaches is fairly priced, but it still costs a bundle